GLACIAL RIDGE HOSPITAL
1. Target Overview & Investment Thesis
GLACIAL RIDGE HOSPITAL is a 19-bed suburban community hospital in POPE, MN with $46.9M in net patient revenue and a -5.3% operating margin. The hospital serves a payer mix of 43.9% Medicare, 2.0% Medicaid, and 54.1% commercial.
Thesis: Turnaround. Our ML models identify $3.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.3% to 2.1% (+736bps).
| Net Revenue HCRIS | $46.9M |
| Current EBITDA COMPUTED | $-2.5M |
| Operating Margin COMPUTED | -5.3% |
| Occupancy HCRIS | 40.3% |
| Revenue / Bed COMPUTED | $2.5M |
| Net-to-Gross HCRIS | 54.6% |
| Distress Probability ML | 51.2% |
2. Market Context & Competitive Position
MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -5.3% places it below the state median. Among 93 size-comparable peers (10-38 beds), the median margin is -2.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (10-38), prioritizing same-state peers. 93 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| GLACIAL RIDGE HOSPITAL (Target) | MN | 19 | $46.9M | -5.3% |
| CUYUNA REGIONAL MEDICAL CENTER | MN | 25 | $180.8M | -4.0% |
| ST. MARYS REGIONAL HEALTH CENT | MN | 36 | $167.8M | 3.1% |
| MAYO CLINIC HEALTH SYSTEM - RE | MN | 27 | $149.3M | 1.8% |
| NEW ULM MEDICAL CENTER | MN | 24 | $128.6M | 4.2% |
| LAKEWOOD HEALTH SYSTEM | MN | 25 | $124.7M | 0.2% |
| NORTHFIELD CITY HOSPITAL | MN | 37 | $121.8M | -8.4% |
| GRAND ITASCA CLINIC AND HOSPIT | MN | 34 | $117.7M | 5.3% |
| AVERA MARSHALL REGIONAL MEDICA | MN | 25 | $115.2M | -17.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $985K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $938K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $928K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $571K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $30K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-2.5M |
| + RCM Uplift | +$3.5M |
| Pro Forma EBITDA | $969K |
| Current Margin | -5.3% |
| Pro Forma Margin | 2.1% |
| WC Released (1x) | $1.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-3.8M | $18.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-3.8M | $18.7M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-3.4M | $28.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-3.4M | $30.5M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-4.2M | $2.1M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-4.2M | $973K | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 51.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 93 hospitals with 10-38 beds
- Same-state prioritization (n=94)
- Comp margins: P25=-12.1% / P50=-2.6% / P75=3.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.